Article

Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized Pedigree

2021-01-06

Abstract excerpt

<title>Abstract</title> <p>Variability of response to medication is a well known phenomenon, determined by both environmental and genetic factors. Understanding the heritable component of the response to medication is of great interest but challenging due to several reasons, including small study cohorts and computational limitations. Here, we studied the heritability of variation in the glycaemic response to met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 38ee60d7-ed8d-53ef-a4e0-cbd7aad65d97
DOI: 10.21203/rs.3.rs-122793/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized PedigreeDOI 10.21203/rs.3.rs-122793/v1Read

Estimating Heritability of Glycaemic Response to Metformin using Nationwide Electronic Health Records and Population-Sized PedigreeSemantic proximity Read

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis.Semantic proximity Read

Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to SulfonylureasSemantic proximity Read

Metformin Pharmacogenomics: Current Status and Future DirectionsSemantic proximity Read

An Update on the Pharmacogenomics of Metformin: Progress, Problems and PotentialSemantic proximity Read

A genetically supported drug repurposing pipeline for diabetes treatment using electronic health recordsSemantic proximity Read

Heritability of metabolic syndrome traits in a large population-based sampleSemantic proximity Read

Estimating heritability in pharmacogenetic studies.Semantic proximity Read

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 DiabetesSemantic proximity Read

Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study.Semantic proximity Read

Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medicationsSemantic proximity Read

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read